Download the list of NSQ samples for November 2022, the link is given below: The Central Drugs Standard Control Organisation (CDSCO) has declared 83 drug samples out of a total of 1404 drug samples tested as not of standard quality (NSQ) and none as misbranded or spurious during the month of November 2022.

Click here to download NSQ list November 2022

Out of the 1487 samples tested during the month, 1404 samples came out with standard quality, while 83 samples were declared as not of standard quality (NSQ) & none declared as misbranded, and none as spurious.

Picture: Pixabay

None of the samples were identified as spurious and none declared as adulterated during the month. Every month, the drug regulator comes up with a list of drugs, medical devices, and cosmetics that are declared not of standard quality / spurious / adulterated / misbranded, every month.

Click to download month and year wise lists of NSQ drugs

During the month of October 2022, the authorities tested 1280 samples, out of which 1230 samples were tested as of standard quality. The number of samples declared as not of standard quality was 50 and none as misbranded and none as spurious.

During the month of September, 2022, the authorities tested 1456 samples, out of which 1397 samples were tested as of standard quality. The number of samples declared as not of standard quality was 59 and none as misbranded and none as spurious.

During the month of August, 2022, the authorities tested 1330 samples, out of which 1285 samples were tested as of standard quality. The number of samples declared as not of standard quality was 45 and none as misbranded and none as spurious.

During the month of July, 2022, the authorities tested 1337 samples, out of which 1283 samples were tested as of standard quality. The number of samples declared as not of standard quality was 53 and one as misbranded and none as spurious.

During the month of June, 2022, the authorities tested 1096 samples, out of which 1070 samples were tested as of standard quality. The number of samples declared as not of standard quality was 26 and none as misbranded and spurious.

During the month of May, 2022, the authorities tested 1233 samples, out of which 1192 samples were tested as of standard quality. The number of samples declared as not of standard quality was 41 and none as misbranded and spurious.

During the month of April, 2022, the authorities tested 1164 samples, out of which 1137 samples were tested as of standard quality. The number of samples declared as not of standard quality was 27 and none as misbranded and spurious.

During the month of March, 2022, the authorities tested 1454 samples, out of which 1406 samples were tested as of standard quality. The number of samples declared as not of standard quality was 48 and none as misbranded.

During the month of February, 2022, the authorities tested 1221 samples, out of which 1181 samples were tested as of standard quality. The number of samples declared as not of standard quality was 39 and one as misbranded.

The test samples were drawn by the zonal and sub-zonal offices of CDSCO, and tested in the drug testing laboratories i.e CDL, CDTLs & RDTLs in Kolkata, Mumbai, Hyderabad, Chandigarh, and Guwahati.

Month wise drug alerts, click to download below links

Drug alert: 50 out of 1280 samples declared as NSQ in October 2022

Drug alert: 59 out of 1456 samples declared as NSQ in September 2022

Drug alert: 45 out of 1330 samples declared as NSQ in August 2022

Drug alert: 53 out of 1337 samples declared as NSQ in July 2022

Drug alert: 26 out of 1096 samples declared as NSQ in June 2022

Drug alert: 41 out of 1233 samples declared as NSQ in May 2022

Drug alert: 27 out of 1164 samples declared as NSQ in April 2022

Drug alert: 48 out of 1454 samples declared as NSQ in March 2022

Drug alert: 40 out of 1221 samples declared as NSQ in February 2022

Drug alert: 27 out of 1227 samples declared as NSQ in January 2022

Medical Device Alert: Lists

Safety alerts issued by IPC

Commercial Testing Laboratories

Govt Laboratories

List of Laboratory instruments

Latest Notifications: Testing Laboratories

FDA: Patients cannot be forced to buy medicines from hospital-attached pharmacies

Pharmacy education needs to adopt 2D, 3D format for lectures

Indian Pharma Companies have potential in Saudi Arabia

USFDA gives nod for Silodosin, Pregabalin Capsules

Parliament panel recommendation for National Commission on Medical Devices

Homoeopathy: Commission notifies BHMS Regulations 2022

USFDA gives final approval for Desonide cream

Gujarat sets up new 784 manufacturing units during the last one year

National roundtable on safe Blood Transfusions

Latest Notifications regarding Pharmaceuticals
https://thehealthmaster.com/2022/12/13/drug-alert-83-out-of-1487-samples-declared-as-nsq-in-november-2022/